# Hope Bancorp Inc: financial statements, quarterly

HOPE · Nasdaq · CIK 1128361 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hope.md) · [Financials](/companies/hope/financials.md) · [Filings](/companies/hope/filings.md) · [Insiders](/companies/hope/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hope/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [140](/filings/0001128361-25-000010.md) | [143](/filings/0001128361-25-000010.md) | [145](/filings/0001128361-26-000011.md) | [127](/filings/0001128361-26-000011.md) | [130](/filings/0001128361-26-000011.md) | [124](/filings/0001128361-26-000011.md) | [116](/filings/0001128361-26-000011.md) | [122](/filings/0001128361-26-000011.md) | [118](/filings/0001128361-26-000011.md) | [113](/filings/0001128361-26-000011.md) | not reported | not reported |
| Income tax | $m | [10.0](/filings/0001128361-25-000010.md) | [7.1](/filings/0001128361-25-000010.md) | [10.0](/filings/0001128361-26-000011.md) | [9.3](/filings/0001128361-26-000011.md) | [7.9](/filings/0001128361-26-000011.md) | [6.1](/filings/0001128361-26-000011.md) | [6.7](/filings/0001128361-26-000028.md) | [(1.3)](/filings/0001128361-26-000037.md) | [5.6](/filings/0001128361-26-000011.md) | [4.7](/filings/0001128361-26-000011.md) | [8.4](/filings/0001128361-26-000028.md) | [9.6](/filings/0001128361-26-000037.md) |
| Net income | $m | [30.0](/filings/0001128361-25-000010.md) | [26.5](/filings/0001128361-25-000010.md) | [25.9](/filings/0001128361-26-000011.md) | [25.3](/filings/0001128361-26-000011.md) | [24.2](/filings/0001128361-26-000011.md) | [24.3](/filings/0001128361-26-000011.md) | [21.1](/filings/0001128361-26-000028.md) | [(24.8)](/filings/0001128361-26-000037.md) | [30.8](/filings/0001128361-26-000011.md) | [34.5](/filings/0001128361-26-000011.md) | [29.5](/filings/0001128361-26-000028.md) | [33.0](/filings/0001128361-26-000037.md) |
| Diluted EPS | $ per share | [0.25](/filings/0001128361-25-000010.md) | [0.22](/filings/0001128361-25-000010.md) | [0.21](/filings/0001128361-26-000011.md) | [0.21](/filings/0001128361-26-000011.md) | [0.20](/filings/0001128361-26-000011.md) | [0.20](/filings/0001128361-26-000011.md) | [0.17](/filings/0001128361-26-000028.md) | [(0.19)](/filings/0001128361-26-000037.md) | [0.24](/filings/0001128361-26-000011.md) | [0.27](/filings/0001128361-26-000011.md) | [0.23](/filings/0001128361-26-000028.md) | [0.26](/filings/0001128361-26-000037.md) |
| Basic EPS | $ per share | [0.25](/filings/0001128361-25-000010.md) | [0.22](/filings/0001128361-25-000010.md) | [0.22](/filings/0001128361-26-000011.md) | [0.21](/filings/0001128361-26-000011.md) | [0.20](/filings/0001128361-26-000011.md) | [0.20](/filings/0001128361-26-000011.md) | [0.17](/filings/0001128361-26-000028.md) | [(0.19)](/filings/0001128361-26-000037.md) | [0.24](/filings/0001128361-26-000011.md) | [0.27](/filings/0001128361-26-000011.md) | [0.23](/filings/0001128361-26-000028.md) | [0.26](/filings/0001128361-26-000037.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [20.1](/filings/0001128361-23-000051.md) | [19.1](/filings/0001128361-25-000010.md) | [18.1](/filings/0001128361-24-000016.md) | [17.4](/filings/0001128361-24-000030.md) | [17.4](/filings/0001128361-24-000039.md) | [17.1](/filings/0001128361-26-000011.md) | [17.1](/filings/0001128361-25-000026.md) | [18.5](/filings/0001128361-25-000036.md) | [18.5](/filings/0001128361-25-000046.md) | [18.5](/filings/0001128361-26-000037.md) | [18.7](/filings/0001128361-26-000028.md) | [19.0](/filings/0001128361-26-000037.md) |
| Total liabilities | $bn | [18.0](/filings/0001128361-23-000051.md) | [17.0](/filings/0001128361-25-000010.md) | [16.0](/filings/0001128361-24-000016.md) | [15.3](/filings/0001128361-24-000030.md) | [15.2](/filings/0001128361-24-000039.md) | [14.9](/filings/0001128361-26-000011.md) | [14.9](/filings/0001128361-25-000026.md) | [16.3](/filings/0001128361-25-000036.md) | [16.3](/filings/0001128361-25-000046.md) | [16.2](/filings/0001128361-26-000037.md) | [16.4](/filings/0001128361-26-000028.md) | [16.7](/filings/0001128361-26-000037.md) |
| Short-term borrowings | $bn | [1.8](/filings/0001128361-23-000051.md) | [1.8](/filings/0001128361-25-000010.md) | [0.8](/filings/0001128361-24-000016.md) | [0.2](/filings/0001128361-24-000030.md) | [0.1](/filings/0001128361-24-000039.md) | [0.2](/filings/0001128361-26-000011.md) | [0.1](/filings/0001128361-25-000026.md) | [0.0](/filings/0001128361-25-000036.md) | [0.0](/filings/0001128361-25-000046.md) | [0.3](/filings/0001128361-26-000037.md) | [0.3](/filings/0001128361-26-000028.md) | [0.5](/filings/0001128361-26-000037.md) |
| Shareholders' equity | $bn | [2.0](/filings/0001128361-24-000039.md) | [2.1](/filings/0001128361-26-000011.md) | [2.1](/filings/0001128361-25-000036.md) | [2.1](/filings/0001128361-25-000046.md) | [2.2](/filings/0001128361-25-000046.md) | [2.1](/filings/0001128361-26-000037.md) | [2.2](/filings/0001128361-26-000037.md) | [2.2](/filings/0001128361-26-000037.md) | [2.3](/filings/0001128361-25-000046.md) | [2.3](/filings/0001128361-26-000037.md) | [2.3](/filings/0001128361-26-000037.md) | [2.3](/filings/0001128361-26-000037.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [193 d](/filings/0001128361-24-000039.md) | [78.6 d](/filings/0001128361-26-000011.md) | [29.6](/filings/0001128361-25-000026.md) | [(25.6) d](/filings/0001128361-25-000036.md) | [63.0 d](/filings/0001128361-25-000046.md) | [49.6 d](/filings/0001128361-26-000011.md) | [26.7](/filings/0001128361-26-000028.md) | [9.3 d](/filings/0001128361-26-000037.md) | [51.9 d](/filings/0001128361-25-000046.md) | [76.8 d](/filings/0001128361-26-000011.md) | [13.8](/filings/0001128361-26-000028.md) | [60.4 d](/filings/0001128361-26-000037.md) |
| Capital expenditure | $m | [3.4 d](/filings/0001128361-24-000039.md) | [2.0 d](/filings/0001128361-26-000011.md) | [2.1](/filings/0001128361-25-000026.md) | [2.5 d](/filings/0001128361-25-000036.md) | [2.9 d](/filings/0001128361-25-000046.md) | [2.3 d](/filings/0001128361-26-000011.md) | [2.7](/filings/0001128361-26-000028.md) | [2.5 d](/filings/0001128361-26-000037.md) | [4.6 d](/filings/0001128361-25-000046.md) | [3.4 d](/filings/0001128361-26-000011.md) | [2.0](/filings/0001128361-26-000028.md) | [4.4 d](/filings/0001128361-26-000037.md) |
| Share repurchases | $m | [0.0 d](/filings/0001128361-23-000051.md) | [0.0 d](/filings/0001128361-25-000010.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001128361-26-000028.md) | [0.0 d](/filings/0001128361-26-000037.md) | not reported | not reported | [6.7](/filings/0001128361-26-000028.md) | [2.0 d](/filings/0001128361-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [120](/filings/0001128361-23-000051.md) | [120](/filings/0001128361-24-000016.md) | [120](/filings/0001128361-24-000030.md) | [120](/filings/0001128361-24-000039.md) | [121](/filings/0001128361-25-000026.md) | [121](/filings/0001128361-25-000036.md) | [121](/filings/0001128361-25-000046.md) | [121](/filings/0001128361-26-000028.md) | [128](/filings/0001128361-26-000037.md) | [129](/filings/0001128361-25-000046.md) | [129](/filings/0001128361-26-000028.md) | [128](/filings/0001128361-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 127,741,836 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001128361-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.